ArticleNature communications2026

Tumors hijack immune-privileging regulons via distinct cell types to confer T cell desertion and immunotherapy resistance across various cancers.

Bashir Lawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.